You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
京新藥業(002020.SZ)捐贈1000萬元用於支援抗擊肺炎疫情
格隆匯 02-02 18:48

格隆匯2月2日丨京新藥業(002020.SZ)公佈,公司於2020年1月27日召開第七屆董事會第六次會議,審議通過了《關於抗擊新型冠狀病毒對外捐贈的議案》,針對此次新型冠狀病毒感染引發的肺炎疫情,同意公司對外捐贈現金500萬元人民幣和價值500萬元的藥品物資,合計約1000萬元。

湖北省武漢市等新型冠狀病毒感染引發的肺炎疫情不斷蔓延,嚴重威脅着人民羣眾的身體健康和生命安全,為了更好地履行醫藥企業的社會責任,公司擬通過“浙江省紅十字會”向此次肺炎疫情特重災區和救援醫務工作人員捐贈現金500萬元人民幣和價值500萬元的藥品物資,包括益生菌製劑京常樂(地衣芽孢桿菌活菌膠囊)、抗感染藥物京必妥新(左氧氟沙星片)及康復新液、阿奇黴素片等相關藥品,合計約1000萬元,專項用於支援抗擊肺炎疫情。

截止公告日,500萬元愛心捐款已轉賬至浙江省紅十字會賬户,500萬元藥品物資即將發往湖北省的相關疫情定點診治醫院,支持一線疫情防治工作。

此次對外捐贈是為了更好支持疫情防治工作,符合公司積極履行社會責任的要求,有利於提升企業社會形象。此次對外捐贈資金的來源為公司自有資金,不會對公司整體生產經營構成重大影響,不會對公司當期及未來生產經營產生不利影響,不存在損害中小股東利益的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account